Programmed death ligand-2 (PD-L2) is a less studied ligand to PD-1 and has yet to be fully explored, especially in pancreatic ductal adenocarcinoma (PDAC). This evidence concerns the gene PDCD1 and pancreatic ductal adenocarcinoma.